Albuterol Sulfate Solution
Product Images NDC 51662-1499

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 51662-1499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Sleeve Labeling (5 X 3 Vial Sleeve Labeling)

Sleeve Labeling (5 X 3 Vial Sleeve Labeling)
This is an instruction manual for using Albuterol Sulfate inhalation solution. The solution is packaged in a foil pouch and comprises 2.5mg albuterol sulfate/3 mL. The user is to remove one vial from the foil pouch and twist open the cap to squeeze the content into the nebulizer. The nebulizer should then be connected to the compressor, and the mouthpiece or face mask should be fixed to the nebulizer. The user should sit in a comfortable, upright position and breathe in as calmly, deeply, and evenly as possible through the mouth. The treatment is complete after this step. The pharmacist should detach the "patient's instructions for use" from the package insert, and the nebulizer should be cleaned according to the manufacturer's instructions.*
FDA Label Image

Adverse (Adverse)

Adverse (Adverse)
The text presents the percent incidence of moderate to severe adverse reactions caused by Albuterol and Isoproterenol, including symptoms related to the central nervous system, cardiovascular, respiratory and gastrointestinal systems. The symptoms include tremors, headache, insomnia, hypertension, arrhythmias, bronchospasm, cough, bronchitis, wheeze, sputum increase, dyspnea, nausea, dyspepsia, and malaise.*
FDA Label Image

Patient Package Insert (Patient Package Insert)

Patient Package Insert (Patient Package Insert)
Albuterol Sulfate Inhalation Solution is a unit-dose vial that delivers 25mg/3mL of medication without any dilution required. It is equivalent to 3mg of albuterol sulfite. The nebulizer treatment process is simple and requires sitting in a comfortable, upright position while breathing calmly, deeply, and evenly for 5-15 minutes. The nebulizer should then be cleaned according to the manufacturer's instructions. It is essential to follow the complete instructions and use only as directed by a physician. The product must be stored at a temperature between 2° and 25° C (36° and 77° F) and kept in the foil pouch until ready to use.*
FDA Label Image

Serialized Labeling P1 (Serialized Labeling P 1)

Serialized Labeling P1 (Serialized Labeling P 1)
This text seems to be a set of instructions for using a nebulizer. It includes information on how to properly place the mouthpiece or mask, squeezing the nebulizer, and the specific model for which the instructions are designed. Contact information for customer service is also provided.*
FDA Label Image

Serialized Labeling P2 (Serialized Labeling P2)

Serialized Labeling P2 (Serialized Labeling P2)
This text is the description of a medication called "Albuterol Sulfate Inhalation Solution" in unit-dose vials. It is for oral inhalation and contains 1 mg albuterol sulfate per mL, equivalent to 0.83 mg albuterol. It is diluted with normal saline and contains no preservatives. The recommended dosage is listed on the package insert and it should be stored between 2° and 25°C. The pharmacist needs to detach the "Patient's Instructions for Use" from the package insert and dispense it with the solution.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.